Psychiatric Defense Vanishes in Luigi Mangione Trial

Why did Luigi Mangione’s psychiatric defense appear in court, then disappear before prosecutors got the records behind it?

Luigi Mangione’s lawyers withdrew their plan to use a psychiatric defense in his New York state murder trial over the killing of UnitedHealthcare CEO Brian Thompson, reversing course one day after saying they intended to argue he was suffering from extreme emotional disturbance at the time of the Dec. 4, 2024, shooting, Independent World reported.

The move does not end the case. It changes the shape of the trial heading toward a scheduled Sept. 8 start in state court, where Mangione has pleaded not guilty.

Why did Luigi Mangione’s psychiatric defense vanish after one day?

In a one-line court filing Thursday, Mangione’s defense said it “respectfully withdraws” its notice under New York’s psychiatric defense statute.

That notice mattered because Mangione’s lawyers were facing a Thursday deadline to give prosecutors evidence supporting the emotional disturbance claim. By withdrawing it, the defense stepped back from a strategy that would have put Mangione’s mental state near the center of the trial.

A spokesperson for Mangione’s lawyers did not immediately respond to a request for comment, while the Manhattan district attorney’s office declined to comment, according to the source material.

The timing is the sharpest part. On Wednesday, Mangione’s team said they intended to argue that the 28-year-old Ivy League graduate suffered from extreme emotional disturbance when Thompson was killed. By Thursday, that path was off the table, at least as a formal psychiatric defense.

That leaves a clear gap in the public record: the defense has not explained why it reversed itself.

“If a defendant goes with an [extreme emotional disturbance] defense, they're essentially admitting publicly that they committed this crime,” Friedman Agnifilo said, according to a transcript cited by ABC News.

That is the strategic pressure point. An emotional disturbance defense could reduce exposure, but it comes with a heavy concession. It effectively tells jurors the defendant committed the act, then asks them to judge the mental and emotional context.

How would extreme emotional disturbance have changed the murder trial?

An extreme emotional disturbance defense is not the same as an insanity defense. It would not send Mangione to a psychiatric facility instead of prison.

If accepted by a jury, it could have reduced Mangione’s culpability from murder to a lesser homicide offense, rather than clearing him outright.

That is why the withdrawn strategy was so consequential. It was not a side issue. It could have altered the verdict category itself.

The defense would have had to build a case around Mangione’s mental and emotional condition at the time of Thompson’s killing. Prosecutors, in turn, would have sought records, experts, and evidence to test that claim.

Judge Carro also ordered a transcript from a June 3 closed-door hearing on the issue to be made public. At Wednesday’s hearing, Friedman Agnifilo objected to unsealing materials tied to the psychiatric defense, saying it would be “prejudicial to his defense to the exact same facts” in his federal case, where an extreme emotional disturbance defense is not allowed.

That federal case matters because Mangione also faces federal charges, including stalking charges. His federal trial is expected next year.

For prosecutors, the withdrawal may mean a more conventional trial. That does not mean simpler. It means the case may turn more heavily on identification, intent, physical evidence, writings, and witness testimony, rather than dueling psychiatric narratives.

For the defense, the pivot avoids a public concession that Mangione killed Thompson under mitigating circumstances. It may also limit what prosecutors can demand from psychiatric records, depending on the court’s rulings.

Which evidence now carries more weight before Sept. 8?

The case now shifts back toward the evidence prosecutors say links Mangione to the killing.

Thompson, 50, was shot while walking to a Manhattan hotel for UnitedHealth Group’s annual investor conference. Surveillance video showed a masked gunman shooting him from behind.

Police say “delay,” “deny” and “depose” were written on the ammunition, language that mimicked a phrase used to describe how insurers avoid paying claims.

Mangione was arrested five days later at a McDonald’s in Altoona, Pennsylvania, about 230 miles west of Manhattan. Prosecutors say a 3D-printed pistol matches the gun used to kill Thompson. They also cite a notebook that describes wanting to “wack” a health insurance executive and rebelling against “the deadly, greed fueled health insurance cartel.”

Carro ruled last month that the gun and notebook can be used as evidence against Mangione.

That ruling now looks even more important. If the defense is no longer asking jurors to weigh an extreme emotional disturbance claim, the prosecution’s physical and written evidence may become the spine of the state case.

This is where the next round of pretrial work matters. Expect fights over evidence boundaries, witness lists, jury instructions, and how much of Mangione’s alleged writings prosecutors can put before jurors.

XOOMAR has tracked how high-pressure cases can turn on

Impact Analysis

• The withdrawal reshapes the legal strategy ahead of Mangione’s scheduled Sept. 8 state murder trial.
• It avoids immediate disclosure of psychiatric evidence that prosecutors were due to receive.
• The unexplained reversal leaves uncertainty over how the defense will contest the killing of UnitedHealthcare CEO Brian Thompson.